Table of Contents Table of Contents
Previous Page  659 / 1082 Next Page
Information
Show Menu
Previous Page 659 / 1082 Next Page
Page Background

S643

ESTRO 36 2017

_______________________________________________________________________________________________

test.

Conclusion

Pts opinions underlined that a genetic test could help in

facing RT and its side-effect in a more conscious manner,

and it might help clinician to optimize RT. Nevertheless

side-effect are generally perceivable as tolerable, and

preferable to mastectomy or tumor control failure

EP-1197 Results in Breast cancer Patients who

Received adjuvant Radiation after Immediate

Reconstruction

A. Giraldo Marin

1

1

Hospital Universitario Vall d'Hebron, Radiotherapy,

Barcelona, Spain

Purpose or Objective

Prior studies have advocated avoidance of immediate

reconstruction (IR) in breast cancer (BC) patients who

should receive adjuvant radiotherapy (RT), alluding to

worse aesthetic outcomes. Our purpouse is to evaluate the

complication rates and cosmetic results for patients

undergoing postmastectomy radiation therapy (PMRT)

after IR.

Material and Methods

Between June 2010 and March 2016, 25 patients with

locally advanced breast cancer, who underwent modified

radical mastectomy, IR, and PMRT were treated at our

center. RT was delivered to the chest wall ± nodal areas

according to stage, with 6MV and total dose of 50 Gy in 25

fractions. Complications were scored following the CTCAE

4.0 criteria. The capsular contracture was evaluated

following the Baker classification. Cosmesis was rated as

either acceptable or unacceptable to the patient.

Results

The mean age was 46.7 years (range, 33-65). A total of 20

patients underwent tissue expander and 5 underwent

implant (TE/I). Median follow-up (from the start of RT) for

all patients was 18 months (m) (4-48m). 40% of the

patients were never smokers; 28% were smokers and 32%

ex-smokers during RT. 10% and 68% of the patients

received neoadjuvant and adjuvant chemotherapy

respectively, and 17 patients taking Tamoxifen during RT.

After surgery the complications occurred in 15/25

patients: 7 with capsulitis grade (G) 2; 2 with capsulitis

G3-4; 3 with cutaneous suffering and mastitis, extrusion

and hematoma were presented in 1 patient each.

Complications post surgery in 2 patients as were

hematoma and extrusion required additional surgery and

delayed beginning of RT. All patients completed the RT

course without major complications. During RT the only

complication presented was skin erythema (SE) G1-2 seen

in 20 (80%) and G3 in just 5 patients which were all

smokers. During the follow up the major complications

were: capsulitis G3 in 5 patients and G4 in 1; skin

hyperpigmentation was presented in 4 patients, cutaneous

thinning in 6 and 1 patient presented relevant lung

toxicity. At the end of the follow-up, TE Exchange have

been realized in 12 patients with a mean time after RT of

14,3m (9-22), 3 of them are pending of a new corrective

surgery, specialy for improve cosmetic outcomes. We

reported capsulitas G4 in 2 patients after the Exchange;

both were smokers and 1 of them presented extrusion

before RT, therefore she was operated twice. Acceptable

cosmesis was reported in 60% of the patients

Conclusion

Our experiences is limited but in our patients undergoing

PMRT, RT can be safely delivered after IR, with a low

complication rate and good patient satisfaction. In our

patients major complications occurred before RT. Further

studies are needed to define the factors that may be

related to worse aesthetic results.

EP-1198 Low risk breast cancer patients' supportive

care needs and perceptions of follow-up care options

J. Kwan

1

, J. Croke

1

, J. Bender

2

, T. Panzarella

1

, K. Ubhi

1

,

F. Liu

1

, A. Fyles

1

, A. Koch

1

, R. Dinniwell

1

, W. Levin

1

, D.

McCready

3

, C. Chung

1

1

Princess Margaret Cancer Centre- University Health

Network/ University of Toronto, Radiation Oncology,

Toronto, Canada

2

University Health Network, ELLICSR Cancer Survivorship

Centre, Toronto, Canada

3

Princess Margaret Cancer Centre- University Health

Network/ University of Toronto, Surgical Oncology,

Toronto, Canada

Purpose or Objective

Breast cancer is the most common cancer in women and

survival following treatment is rising. Although traditional

follow-up care has been by oncology specialists post-

treatment, literature over the last decade has shown that

non-specialist follow-up care is a safe alternative for

early-stage breast cancer patients. Barriers in

transitioning patients from oncologist follow-up have not

been well characterized. This study aims to assess i) the

existing follow-up practices at a large institution, ii) met

and unmet supportive care needs, and iii) patient views on

alternative care models, particularly involving primary

care and eHealth.

Material and Methods

A cross-sectional survey of well breast cancer patients

attending radiation oncology follow-up appointments from

August 2012 to May 2013 at the Princess Margaret Cancer

Centre (Toronto, Canada) was completed. Eligibility

criteria included English-speaking patients with T2 or

lower tumor stage, node negative status, and ER/PR-

positive breast cancer treated with radiation. Four

domains were assessed: health care service use,

supportive care needs, perceptions of follow-up care

options, and internet usage. Descriptive statistics were

completed for all variables and univariable analyses were

performed to examine relationships between key variables

and domains.

Results

Response rate was 80% (191/259). Respondents had a

mean age of 60 (SD=10.6). Median time since first follow-

up was 21 months. The majority of respondents (161/191;

84%) received follow-up care from greater than one cancer

specialist and had a median of 3 health care professional

visits per year. The most preferred follow-up model was

specialist care at a tertiary centre (178/191; 93%) and the

least preferred models were specialist care through video

conferencing (29/191; 15%) and email (28/191; 15%).

Shared care models involving a specialist and family

physician were modestly accepted (103/191; 54%).

Primary care only follow-up was not well accepted

(35/191; 18%), particularly among patients with higher

education. Respondents who reported few unmet

supportive care needs (p=0.01) or who search online for

health information (p=0.02) were more likely to report

perceived satisfaction with specialist follow-up via

eHealth.

Conclusion